Cliff Asness's RLAY Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.3 M shares of Relay Therapeutics, Inc. (RLAY) worth $6.79 M, representing 0.00% of the portfolio. First purchased in 2023-Q4, this short-term holding has been held for 8 quarters.
Based on 13F filings, Cliff Asness has maintained this position in RLAY for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 718,519 shares. Largest reduction occurred in Q3 2024, reducing 43,851 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Relay Therapeutics (RLAY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Relay Therapeutics (RLAY) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2023 | +11,501 | New Buy | 11,501 | $11.01 |
| Q1 2024 | +3,049 | Add 26.51% | 14,550 | $8.30 |
| Q2 2024 | +52,693 | Add 362.15% | 67,243 | $6.52 |
| Q3 2024 | -43,851 | Reduce 65.21% | 23,392 | $7.08 |
| Q4 2024 | +302,742 | Add 1294.21% | 326,134 | $4.12 |
| Q1 2025 | +38,812 | Add 11.90% | 364,946 | $2.62 |
| Q2 2025 | +718,519 | Add 196.88% | 1.08 M | $3.46 |
| Q3 2025 | +217,571 | Add 20.08% | 1.3 M | $5.22 |
Cliff Asness's Relay Therapeutics Investment FAQs
Cliff Asness first purchased Relay Therapeutics, Inc. (RLAY) in Q4 2023, acquiring 11,501 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Relay Therapeutics, Inc. (RLAY) for 8 quarters since Q4 2023.
Cliff Asness's largest addition to Relay Therapeutics, Inc. (RLAY) was in Q2 2025, adding 1,083,465 shares worth $3.75 M.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,301,036 shares of Relay Therapeutics, Inc. (RLAY), valued at approximately $6.79 M.
As of the Q3 2025 filing, Relay Therapeutics, Inc. (RLAY) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Relay Therapeutics, Inc. (RLAY) was 1,301,036 shares, as reported at the end of Q3 2025.